In this edition of Our Picks, we asked GOLF staffers to dish on their favorite, go-to golf shoes they can't leave home ...

On November 10, Jennifer Garner stepped out in an outfit I’ll be copying for the holiday season, teaming a classic black ...

Where should the ball be in your stance? And what’s the correct stance width? Cameron McCormick, a GOLF Top 100 teacher, has a system.

You can also use Google’s AdSense, the same ad platform on YouTube, to put relevant ads on your blog ... Requirements Gently worn shoes, clothing and accessories. Items will go through various ...

For example, if your company matches up to 6% of your salary and you contribute 6%, you're doubling what you're able to put away. While the more you can contribute the better, Shannon Lynch ...

The focal point of her ensemble was a pair of heeled sandals from Charles & Keith. Jennifer Lopez arrives to speak during a campaign rally for US Vice President and Democratic presidential ...

Credit: Pixel-Shot via Shutterstock. The European Commission (EC) has imposed a fine of €462.6m ($502m) on Teva Pharmaceuticals Industries after investigating the company’s practices regarding the ...

The Israel-based company said it was 'deeply disappointed' by the EU's fine The EU said Teva had abused its dominant position in the medicine for multiple sclerosis in Belgium, the Czech Republic ...

TEL AVIV – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced its decision to appeal against the European Commission's recent ruling related to its multiple sclerosis drug, COPAXONE®. The ...

Editor's Note: APYs listed in this article are up-to-date as of the time of publication. They may fluctuate (up or down) as the Fed rate changes. CNBC Select will update as changes are made public.

BRUSSELS, Oct 31 (Reuters) - Teva (TEVA.TA), opens new tab, the world's largest generic drugmaker, was hit on Thursday with a 462.6 million euro ($503 million) EU antitrust fine for abusing its ...

Teva Pharmaceuticals is being fined $503 million (€463 million) by the European Commission for delaying competition posed by rival generic drugmakers, the company’s second major financial ...